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Abstract
Differences in public health approaches to control the coronavirus disease 2019 (COVID-19) pandemic could 
largely explain substantial variations in epidemiological indicators (such as incidence and mortality) between 
the West and the East. COVID-19 revealed vulnerabilities of most western countries’ healthcare systems in their 
response to the ongoing public health crisis. Hence, western countries can possibly learn from practices from 
several East Asian countries regarding infrastructures, epidemiological surveillance and control strategies to 
mitigate the public health impact of the pandemic. In this paper, we discuss that the lack of rapid and timely 
community-centered approaches, and most importantly weak public health infrastructures, might have resulted 
in a high number of infected cases and fatalities in many western countries.
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A novel coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), emerged in China’s Wuhan in late 
2019. A few weeks later, the virus spread all around the world. 
On March 11, 2020, the World Health Organization (WHO) 
characterized COVID-19 as a pandemic. As of May 19, 2020, 
a total number of 473 458 confirmed COVID-19 cases and 
316 169 confirmed deaths has been reported globally.1
In the meantime, most high-income western countries have 
been severely hit by the COVID-19 pandemic, resulting in a 
rapid surge in the number of infected cases. For example, as 
of May 19, 2020, six western countries including the United 
States, the United Kingdom, Spain, Italy, Germany, and 
France accounted for more than half of the global confirmed 
COVID-19 cases (ie, 2 497 125 out of 4 731 458) as well as 
for above two-thirds of COVID-19 deaths (ie, 219 981 out of 
316 169), respectively.1 Adding other western countries such 
as Belgium, the Netherlands, Canada, Switzerland, Portugal, 
Austria, and Sweden to this list further demonstrates the 
devastating impact of this pandemic on western countries. 
Such a circumstance appears to conflict with the considerable 
progress achieved in western countries in control of 
communicable diseases over the past several decades. While 
the health systems of most western countries have prioritized 
hospital-centered management of non-communicable 
diseases, their capacity to prevent and control emerging 
infectious diseases has not been given adequate attention, 
with relatively limited public investments to strengthen 
epidemiological surveillance systems in the community.2 
In case of the ongoing COVID-19 pandemic, most western 
countries have missed the boat by not using the golden window 
period at the early days of the spread of epidemic that the East 
Asian countries used to halt the COVID-19 epidemic. Here, 
we discuss that a lack of pandemic preparedness in western 
countries necessitates them to strengthen early responses and 
community-centered public health systems, which are in place 
in some of the East Asian countries.
COVID-19 Responses in the East 
East Asian countries have been suggested as the most 
successful examples for curbing the COVID-19 epidemic and 
reducing its community transmission. Among other factors, 
a major contributor of such achievements is possibly due to 
their rapid recognition of the COVID-19 threat, and quick 
responses to the epidemic. Here, we present the responses 
to COVID-19 outbreak in some of these countries including 
South Korea, Vietnam, Taiwan, and Hong Kong, and highlight 
that their timely community-centered, public health strategies 
are the key for their success. 
South Korea’s response to the epidemic has been considered 
as one of the most successful models worldwide. Along 
with the most common public health interventions such 
as physical distancing and school closure, South Korea 
implemented multiple important community-centered 
strategies, including but not limited to, rapid expansion of 
the diagnostic capacities in the communities, widespread 
testing and screening programs, along with ongoing and 
extensive efforts in isolating infected cases and tracing and 
putting their contacts in quarantine. Being well-prepared, 
as well as the rapid implementation of the public health 
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responses in the early stages have effectively contributed to 
the control of the epidemic in South Korea. In addition, using 
advanced information technologies helped the authorities 
trace the contacts extensively. Innovative screening tests (eg, 
drive-through and walk-in screening and testing sites) were 
established in the early stages of the epidemic.3,4
Vietnam achieved positive outcomes in controlling the 
epidemic mainly due to the early recognition of the COVID-19 
threat and a swift response. Even though wide-ranging testing 
programs in the community was not affordable, Vietnam 
implemented other whole-of-society approaches including 
case identification, case isolation, extensive contact tracing, 
quarantine of suspected cases, and mass masking aiming 
at reducing community transmissions and controlling the 
infections at sources; all of which were implemented from the 
early days of the spread of the epidemic. Advanced information 
technology was also incorporated into the responses in 
Vietnam; for example, people were made to report the health 
status of themselves and their family members to the national 
response authorities through a mobile application.5,6
In Taiwan, multiple well-trained and experienced 
teams swiftly recognized the COVID-19 crisis after the 
identification of the first COVID-19 cases, and responded 
accordingly. Taiwan enhanced proactive case finding using 
advanced technology, robust and comprehensive contact 
tracing, encouraged quarantine of suspicious cases, reassured 
and educated the public while preventing the circulation 
of misinformation, allocated resources (eg, mass mask 
production) and addressed COVID-19-related stigma for the 
affected cases. Taiwan became an example for “how a society 
can quickly respond to a crisis.”7,8
In Hong Kong, reinforced preparedness to public health 
emergencies enabled a nationwide response to the COVID-19 
epidemic even before the diagnosis of the first case in 
the country. Multiple containment approaches including 
aggressive contact tracing, testing, quarantine of the 
suspected cases, screening, and surveillance programs were 
simultaneously implemented.9,10
COVID-19 Responses in the West
As mentioned above, most western countries have been 
hardly hit by the COVID-19 pandemic. While many western 
countries have also implemented public health measures 
such as border control, social/physical distancing programs, 
testing and contact tracing, majority of them have not been 
as timely and successful as the East countries.11 The less 
successful management of the COVID-19 in the West could 
be largely explained by their delayed response and focusing 
on patient-centered strategies and case management in the 
hospital settings. Of course, among western countries, there 
are some exceptions; for example, Germany is of those well-
praised western countries where the COVID-19 pandemic 
have been effectively managed. Below, we first explain the 
reasons for the success of Germany, and then shortly discuss 
the story of other countries such as the United States, the 
United Kingdom, Italy, Spain and France in combating the 
COVID-19 epidemic. 
In the European region, Germany is an exemplary, much-
praised country with their responses to the COVID-19 
epidemic. Given its large number of affected cases (ie, 175 210 
by May 19, 2020), only 8007 deaths were reported (ie, case-
fatality rate [CFR] = 4.5%).1 The CFR in Germany is much 
lower than other countries in Europe, such as Belgium, the 
United Kingdom, Italy, Spain, and France, as well as the 
United States.1,11 Although countries’ demographic and 
socioeconomic profile should be also taken into account for 
the COVID-19 fatality rates,11 Germany’s low CFR could be 
better explained by their early responses through widespread 
testing programs among a wide-ranging number of people 
in the community. Compared to other countries conducting 
targeted testing for either their vulnerable populations (eg, 
elderly people) or individuals with severe health status, 
Germany’s extensive testing policy even identified milder cases 
in non-vulnerable groups (eg, younger ages). Additionally, 
unlike many other countries, Germany expanded testing 
laboratories across the country and did not purely rely on the 
central laboratories. Furthermore, it has been suggested that 
unlike other countries, Germany did not report considerable 
community transmission among senior populations, who have 
been found to be one of the most vulnerable groups. However, 
Germany like the East countries started the COVID-19 
responses much quicker than other western countries to slow 
down the circulation of the epidemic, as a result of a strong 
political leadership and commitment.12 
Some of the other western countries, including Italy, France, 
Spain, Belgium, Sweden, the United Kingdom, and the United 
States has not been considered as successful combating the 
COVID-19 pandemic. These countries have commonly given 
a substantially late response to the epidemic. For example, 
Italy implemented more intensified public health response 
interventions including restricted movement of people and 
social activities in its most affected region, Lombardy, on 
March 8, when approximately 12 000 confirmed cases and 800 
deaths were reported.13 France, Spain, and Italy implemented 
total country lockdown in early-mid March but weeks after 
their first cases of COVID-19. Neither of the three countries 
initiated mass testing, while France had to revisit and extend 
their testing policy as a potential solution to end lockdown.14 
In the United States and the United Kingdom, the political 
leaders hampered the timely response to COVID-19 pandemic 
due underestimating negative impacts of the viral spread in 
the community and ignoring the advice of their scientific 
advisors. Both countries came to implement total lockdown 
and substantial number of tests, but very late. The final 
example, Sweden, remains an outlier in handling COVID-19 
among Western countries due to a relaxed mitigation strategy. 
The government of Sweden recommended the citizens to keep 
social distance, work from home, and avoid establishing or 
participating large gatherings, and performed limited number 
of tests.
The Right Strategies in the Right Time
Supported by the evidence,9,15 the deployment of community-
centered strategies to detect asymptomatic cases and reduce 
community transmission is considered the Achilles’ heel 
of control of fast-spreading infectious pandemics, while 
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symptom-based screening and management of infected cases 
alone are prone to fail to control community transmission. 
The lack of such timely, coordinated community- and public 
health-centered approaches in responding to the global 
health crisis has the potential to overburden hospitals and 
healthcare systems,11 and lead to a cumulative number of 
patients and deaths. Besides, without an effective community 
approach, the pandemics, together with ensuing economic 
and societal challenges, could aggravate disparities either 
socioeconomically or via accessing appropriate healthcare 
services, in particular, among the most vulnerable 
subpopulations. 
The emerging epidemics and pandemics have signified 
their capacity to become national and international threats, 
with the COVID-19 pandemic as one such threat providing 
us with several excruciating lessons. To reduce their burden, 
western healthcare systems should advance their health 
emergency preparedness and timely responses, reinforcing 
intersectoral collaborations in managing resources, and 
strengthening community responses with stronger public 
health infrastructures and epidemiological surveillance 
systems. Community-based approaches—implemented at 
the right time—are vital to reduce community transmissions 
and manage the response for pandemics until an effective 
vaccine becomes available. Trained staff are an essential part 
of outbreak investigation and control programs. There is a 
need to boost training in infectious disease epidemiology, 
as well as in control and surveillance of communicable 
diseases and emerging infectious diseases. We also agree 
with an existing body of evidence underscoring the need 
for promoting international partnership in mitigation and 
suppression strategies to fight epidemics, expanding national 
and international investments in prevention and control of 
emerging infectious diseases, allocating an adequate supply 
of scarce resources and facilities (eg, personal protective 
equipment), increasing staffing capacities, enhancing 
collaborative research, and transparently sharing data during 
the pandemics.2 In addition, as supported by evidence from 
South Korea4 and Taiwan,7 utilizing the advanced information 
technology system for either tracing cases or aggregating 
critical data are essential in the containment process of the 
epidemics.
Conclusion
Emerging infectious diseases such as COVID-19 require 
timely and rapid community-centered public health 
responses, epidemiological surveillance, and control 
strategies to efficiently contain their spread and reduce their 
associated burden. Health systems in the Western countries 
need to design and pilot such public health-oriented response 
programs to be implemented swiftly and at large scale when 
needed. Health policy-makers and leaders must build and 
maintain strong ties with the rest of the political system in 
their nations to gain support and be trusted when early and 
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